drugset / Trial / NCT00622037

Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality

NCT00622037

Phase 4 Completed 70 enrolled Bp Consulting, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate and compare the effects of PEG-400 based artificial tear and Systane tears in mild-moderate dry eye patients. TBUT, Visual impact and subjective evaluations will be assessed in this month long trial.

Timeline

Start
2008-02
Primary completion
2008-05
Completion
2008-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator PEG-400 Unknown Topical
Comparator Systane Other / unclassified Topical

Indications